Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Chimeric Therapeutics Limited has announced a new application for the quotation of securities, seeking to have 6,841,387 of its ordinary fully paid shares quoted on the ASX under the code CHM. The application was formally submitted on August 30, 2024, as per the details provided in the company’s recent regulatory filing.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.